X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-11-10 | NXGL | Nexgel, Inc. | Kieser Brian Joseph | Interim CEO, 10% | P - Purchase | $5.50 | +133,216 | 133,216 | New | +$732,688 | |||||
| D | 2026-11-10 | NXGL | Nexgel, Inc. | Glassman Steven Mark | Dir | P - Purchase | $5.50 | +4,546 | 12,379 | +58% | +$25,003 | |||||
| M | 2026-11-06 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | S - Sale | $1.34 | -3,335,411 | 7,325,577 | -31% | -$4,479,146 | |||||
2026-11-09 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.99 | +40,000 | 7,325,577 | +1% | +$79,600 | ||||||
| DM | 2026-11-12 | ICUI | Icu Medical Inc/De | Finney Elisha W | Dir | S - Sale+OE | $179.00 | -1,765 | 4,871 | -27% | -$315,935 | |||||
| D | 2026-11-11 | HAE | Haemonetics Corp | Maunsell Farris Maryanne | VP, Chief Accounting Officer | S - Sale+OE | $120.99 | -836 | 5,828 | -13% | -$101,148 | |||||
| D | 2026-11-12 | DCTH | Delcath Systems, Inc. | Martell Bridget A | Dir | S - Sale+OE | $21.71 | -22,500 | 0 | -100% | -$488,508 | |||||
| D | 2026-11-11 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.21 | -8,874 | 159,378 | -5% | -$152,681 | |||||
| D | 2026-11-10 | GMED | Globus Medical Inc | Tobin James R | Dir | S - Sale+OE | $75.16 | -41,666 | 0 | -100% | -$3,131,547 | |||||
| D | 2026-11-09 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.00 | -744 | 159,378 | 0% | -$12,649 | |||||
2026-11-09 | STVN | Stevanato Group S.P.A. | Federici William J | Dir | P - Purchase | $13.72 | +20,000 | 78,580 | +34% | +$274,400 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Rtw Investments, LP | 10% | P - Purchase | $5.00 | +1,200,000 | 10,756,063 | +13% | +$6,000,000 | ||||||
2026-11-09 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $12.86 | -3,079 | 69,753 | -4% | -$39,602 | ||||||
2026-11-09 | NVCR | Novocure Ltd | Brackmann Christoph | CFO | S - Sale | $12.86 | -7,343 | 175,499 | -4% | -$94,446 | ||||||
| D | 2026-11-09 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $235.35 | -4,993 | 481,893 | -1% | -$1,175,089 | |||||
2026-11-10 | ATEC | Alphatec Holdings, Inc. | Valentine Keith | Dir | P - Purchase | $6.93 | +35,000 | 299,283 | +13% | +$242,550 | ||||||
| D | 2026-11-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale+OE | $55.74 | -38,900 | 251,983 | -13% | -$2,168,286 | |||||
2026-11-09 | HTFL | Heartflow, Inc. | Verghese Vikram | CFO | S - Sale | $53.15 | -3,587 | 149,587 | -2% | -$190,649 | ||||||
2026-11-06 | STVN | Stevanato Group S.P.A. | Morel Donald E Jr | Dir | P - Purchase | $13.07 | +25,000 | 62,424 | +67% | +$326,750 | ||||||
2026-11-06 | ATRC | Atricure, Inc. | Johnson B Kristine | Dir | S - Sale | $58.48 | -2,452 | 53,502 | -4% | -$143,393 | ||||||
2026-11-04 | TCMD | Tactile Systems Technology Inc | Burke William W | Dir | S - Sale | $27.00 | -5,000 | 50,041 | -9% | -$135,000 | ||||||
| D | 2026-11-05 | BDX | Becton Dickinson & Co | Polen Thomas E Jr | COB, CEO, Pres | S - Sale+OE | $210.00 | -2,993 | 110,163 | -3% | -$628,530 | |||||
| AD | 2026-11-04 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale+OE | $24.88 | -36,241 | 204,611 | -15% | -$901,844 | |||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | P - Purchase | $5.00 | +20,000 | 119,630 | +20% | +$100,000 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Pacitti David | Dir | P - Purchase | $5.00 | +20,000 | 74,750 | +37% | +$100,000 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $5.00 | +5,000 | 1,514,519 | 0% | +$25,000 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Taylor Andrew Lawrence | CFO | P - Purchase | $5.00 | +1,000 | 590,989 | 0% | +$5,000 | ||||||
2026-11-06 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $325.32 | -550,000 | 13,917,258 | -4% | -$178,924,731 | ||||||
| D | 2026-11-05 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.04 | -382 | 159,378 | 0% | -$6,508 | |||||
2026-11-06 | PRCT | Procept Biorobotics Corp | Sharma Pooja | Chief Strat, Marketing Officer | S - Sale | $19.71 | -4,710 | 106,471 | -4% | -$92,853 | ||||||
2026-11-04 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $25.30 | -75,000 | 672,385 | -10% | -$1,897,643 | ||||||
2026-11-04 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $24.80 | -36,241 | 204,611 | -15% | -$898,802 | ||||||
2026-11-04 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | Chief Op, Financial Officer | S - Sale | $25.00 | -3,247 | 211,250 | -2% | -$81,175 | ||||||
| D | 2026-11-04 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $253.00 | -2,500 | 37,406 | -6% | -$632,500 | |||||
2026-11-03 | KMTS | Kestra Medical Technologies, Ltd. | Moran Timothy P. | Chief Business Officer | S - Sale | $29.56 | -3,192 | 63,153 | -5% | -$94,352 | ||||||
2026-11-04 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale | $85.00 | -5,000 | 35,384 | -12% | -$425,000 | ||||||
2026-11-03 | TCMD | Tactile Systems Technology Inc | King Laura G. | Dir | S - Sale | $25.00 | -4,800 | 20,769 | -19% | -$120,000 | ||||||
2026-11-04 | ATRC | Atricure, Inc. | Privitera Salvatore | Chief Technical Officer | S - Sale | $65.00 | -8,404 | 134,341 | -6% | -$546,260 | ||||||
2026-11-04 | PLSM | Pulsenmore Ltd. | Sonnenschein Elazar | CEO | P - Purchase | $1.70 | +9,259 | 892,421 | +1% | +$15,740 | ||||||
| D | 2026-11-02 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $20.89 | -20,000 | 97,130 | -17% | -$417,820 | |||||
| D | 2026-11-03 | CARL | Carlsmed, Inc. | Bertolini Jeffrey | COO | S - Sale+OE | $15.15 | -747 | 22,489 | -3% | -$11,317 | |||||
2026-11-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $16.90 | -370 | 54,143 | -1% | -$6,253 | ||||||
2026-11-02 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale | $13.24 | -660 | 202,567 | 0% | -$8,738 | ||||||
2026-11-02 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Pres, Global Limb Recon | S - Sale | $9.07 | -150 | 50,769 | 0% | -$1,361 | ||||||
| D | 2026-10-30 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale+OE | $238.97 | -44,436 | 37,328 | -54% | -$10,618,980 | |||||
2026-11-02 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $5.74 | -15,000 | 1,106,402 | -1% | -$86,100 | ||||||
2026-10-29 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $22.11 | -29,665 | 240,852 | -11% | -$655,745 | ||||||
2026-10-29 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | Chief Op, Financial Officer | S - Sale | $22.50 | -3,738 | 214,497 | -2% | -$84,105 | ||||||
| D | 2026-10-30 | CARL | Carlsmed, Inc. | Bertolini Jeffrey | COO | S - Sale+OE | $15.80 | -243 | 22,489 | -1% | -$3,839 | |||||
2026-10-30 | ATEC | Alphatec Holdings, Inc. | Demski David M | Dir | P - Purchase | $6.81 | +60,000 | 491,635 | +14% | +$408,600 | ||||||
2026-10-30 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $2.27 | +18,000 | 10,620,988 | 0% | +$40,860 | ||||||
| M | 2026-10-28 | ANGO | Angiodynamics Inc | Trowbridge Stephen A | EVP, CFO | S - Sale | $12.26 | -25,335 | 280,461 | -8% | -$310,688 | |||||
| DM | 2026-10-27 | KMTS | Kestra Medical Technologies, Ltd. | Mahboob Vaseem | CFO | S - Sale+OE | $30.30 | -79,500 | 60,609 | -57% | -$2,408,590 | |||||
| D | 2026-10-27 | KMTS | Kestra Medical Technologies, Ltd. | Umberger Traci S | See Remarks | S - Sale+OE | $30.03 | -30,000 | 195,825 | -13% | -$900,882 | |||||
2026-10-29 | UTMD | Utah Medical Products Inc | Cornwell Kevin L | COB, CEO | P - Purchase | $66.75 | +1,000 | 189,472 | +1% | +$66,750 | ||||||
2026-10-27 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $22.00 | -2,650 | 174,740 | -1% | -$58,300 | ||||||
| D | 2026-10-27 | TNDM | Tandem Diabetes Care Inc | Twomey Christopher J | Dir | S - Sale+OE | $19.15 | -1,700 | 37,114 | -4% | -$32,555 | |||||
2026-10-27 | DXCM | Dexcom Inc | Stern Sadie | EVP Chief People, Culture Off | S - Sale | $78.62 | -2,565 | 120,913 | -2% | -$201,660 | ||||||
2026-10-26 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $20.00 | -821 | 54,513 | -1% | -$16,420 | ||||||
2026-10-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $198.13 | -76 | 19,568 | 0% | -$15,058 | ||||||
| D | 2026-10-22 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $55.01 | -23,933 | 218,993 | -10% | -$1,316,554 | |||||
2026-10-23 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $255.00 | -400 | 12,318 | -3% | -$102,000 | ||||||
| D | 2026-10-21 | KMTS | Kestra Medical Technologies, Ltd. | Umberger Traci S | See Remarks | S - Sale+OE | $27.18 | -100,000 | 195,825 | -34% | -$2,718,318 | |||||
2026-10-20 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $29.56 | -15,000 | 445,215 | -3% | -$443,389 | ||||||
| M | 2026-10-13 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.71 | +78,855 | 21,125,803 | 0% | +$56,127 | |||||
2026-10-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP Chief Legal Compliance Off | S - Sale | $85.48 | -1,700 | 98,185 | -2% | -$145,316 | ||||||
2026-10-14 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $17.35 | -775 | 55,334 | -1% | -$13,446 | ||||||
2026-10-15 | QTEX | Qtrex Quantum Ltd. | Parnes Tal | Dir | P - Purchase | $1.50 | +6,666 | 766,666 | +1% | +$9,999 | ||||||
2026-10-12 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $49.57 | -38,900 | 283,014 | -12% | -$1,928,195 | ||||||
2026-10-12 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $20.05 | -38,006 | 747,385 | -5% | -$762,013 | ||||||
2026-10-13 | XAIR | Beyond Air, Inc. | Lin Yi-Chien | 10% | P - Purchase | $2.21 | +2,607 | 148,000 | +2% | +$5,761 | ||||||
2026-10-13 | QTEX | Qtrex Quantum Ltd. | Ben-Noon Dagi Shahar | CEO | P - Purchase | $1.49 | +14,093 | 3,678,407 | 0% | +$20,999 | ||||||
2026-10-08 | MDLN | Medline Inc. | Gic Private Ltd | 10% | S - Sale | $35.15 | -7,816,987 | 85,862,312 | -8% | -$274,767,093 | ||||||
2026-10-09 | QTEX | Qtrex Quantum Ltd. | Ben-Noon Dagi Shahar | CEO | P - Purchase | $1.67 | +18,181 | 3,664,314 | 0% | +$30,362 | ||||||
| D | 2026-10-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $226.34 | -4,991 | 481,893 | -1% | -$1,129,637 | |||||
2026-10-05 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $164.45 | -1,527 | 69,291 | -2% | -$251,120 | ||||||
2026-10-05 | TLSI | Trisalus Life Sciences, Inc. | Cox Bryan F. | CHIEF OF RESEARCH | S - Sale | $4.39 | -296 | 162,805 | 0% | -$1,299 | ||||||
2026-10-05 | TLSI | Trisalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | S - Sale | $4.39 | -325 | 127,994 | 0% | -$1,427 | ||||||
2026-10-05 | TLSI | Trisalus Life Sciences, Inc. | Stevens Jennifer | Chief Regulatory Officer | S - Sale | $4.39 | -316 | 123,794 | 0% | -$1,387 | ||||||
| M | 2026-10-02 | MDLN | Medline Inc. | Gic Private Ltd | 10% | S - Sale | $34.90 | -20,678,630 | 93,679,299 | -18% | -$721,644,227 | |||||
| D | 2026-10-05 | CARL | Carlsmed, Inc. | Bertolini Jeffrey | COO | S - Sale+OE | $14.39 | -747 | 22,489 | -3% | -$10,749 | |||||
| D | 2026-10-01 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $18.47 | -20,000 | 97,130 | -17% | -$369,400 | |||||
2026-10-01 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $18.96 | -370 | 56,109 | -1% | -$7,015 | ||||||
2026-10-02 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $8.85 | -2,988 | 261,990 | -1% | -$26,453 | ||||||
2026-10-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $8.85 | -25,260 | 639,449 | -4% | -$223,627 | ||||||
2026-10-02 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $8.85 | -7,208 | 216,829 | -3% | -$63,812 | ||||||
2026-10-01 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $9.05 | -7,797 | 1,975,075 | 0% | -$70,555 | ||||||
2026-10-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $9.05 | -29,653 | 6,092,819 | 0% | -$268,330 | ||||||
2026-10-01 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Pres, Global Limb Recon | S - Sale | $9.44 | -150 | 50,919 | 0% | -$1,416 | ||||||
| M | 2026-09-29 | XAIR | Beyond Air, Inc. | Lin Yi-Chien | 10% | P - Purchase | $2.77 | +20,393 | 145,393 | +16% | +$56,590 | |||||
2026-10-01 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $6.36 | -15,000 | 1,121,402 | -1% | -$95,400 | ||||||
2026-09-30 | KMTS | Kestra Medical Technologies, Ltd. | Cohen Raymond W | Dir | S - Sale | $29.28 | -3,330 | 54,790 | -6% | -$97,504 | ||||||
| D | 2026-09-30 | CARL | Carlsmed, Inc. | Bertolini Jeffrey | COO | S - Sale+OE | $13.99 | -243 | 22,489 | -1% | -$3,400 | |||||
2026-09-30 | RDGL | Vivos Inc | Korenko Michael K | CEO | P - Purchase | $0.50 | +200,000 | 11,635,090 | +2% | +$99,600 | ||||||
2026-09-28 | STVN | Stevanato Group S.P.A. | Stocchi Mauro | See Remarks | S - Sale | $21.50 | -13,649 | 400,000 | -3% | -$293,454 | ||||||
2026-09-28 | DXCM | Dexcom Inc | Stern Sadie | EVP Chief People, Culture Off | S - Sale | $86.15 | -2,565 | 123,478 | -2% | -$220,975 | ||||||
2026-09-28 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $183.70 | -76 | 19,644 | 0% | -$13,961 | ||||||
2026-09-28 | QTEX | Qtrex Quantum Ltd. | Ben-Noon Dagi Shahar | CEO | P - Purchase | $0.71 | +168,894 | 3,646,133 | +5% | +$119,543 | ||||||
2026-09-25 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $154.28 | -1,615 | 70,818 | -2% | -$249,158 | ||||||
| DM | 2026-09-11 | HRGN | Harvard Apparatus Regenerative Technology, Inc. | He Junli | CEO | P - Purchase | $1.07 | +368,630 | 1,332,930 | +38% | +$394,459 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |